An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).

類似資料

• Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
  著者:: Clarke, P, 等
  出版事項: (2001)
• Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.
  著者:: Gray, A, 等
  出版事項: (2000)
• Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.
  著者:: Gray, A, 等
  出版事項: (2000)
• Ethnic differences in diabetic nephropathy - The UKPDS
  著者:: Stevens, R, 等
  出版事項: (1999)
• Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.
  著者:: Stearne, MR, 等
  出版事項: (1998)